# Filana Therapeutics, Inc.: filings

FLNA · Nasdaq · CIK 1069530 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/flna.md) · [Financials](/companies/flna/financials.md) · [Filings](/companies/flna/filings.md) · [Insiders](/companies/flna/insiders.md)

## Reports and events: 307 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 336, 8-K 212, SC 13G/A 83, 10-Q 53, SC 13G 25, 10-K 18, DEF 14A 18, 3 13, 424B5 9, CORRESP 9, UPLOAD 9, EFFECT 6, 4/A 5, 5 5, CT ORDER 5, S-3 5, 8-K/A 4, ARS 4, PRE 14A 4, S-3/A 4, 424B2 3, S-8 3, SCHEDULE 13G/A 3, 144 2, 8-A12G/A 2, S-3ASR 2, 10-K/A 1, 25-NSE 1, 424B3 1, 8-A12B 1, 8-A12G 1, CERT 1, D 1, DEFA14A 1, FWP 1, S-1 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 12:17 ET | [8-K](/filings/0001437749-26-032971.md) | 8.01 Other events | 0001437749-26-032971 |
| 2026-09-22 | 12:00 ET | [8-K](/filings/0001171843-26-006161.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-006161 |
| 2026-09-18 | 20:16 ET | [8-K](/filings/0001437749-26-030751.md) | 3.01 Delisting notice | 0001437749-26-030751 |
| 2026-07-29 | 12:28 ET | [10-Q](/filings/0001437749-26-024752.md) | Quarterly report, period 2026-06-30 | 0001437749-26-024752 |
| 2026-07-29 | 12:15 ET | [8-K](/filings/0001171843-26-004982.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-004982 |
| 2026-06-15 | 10:23 ET | [8-K](/filings/0001437749-26-020562.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-020562 |
| 2026-05-07 | 21:16 ET | [10-Q](/filings/0001437749-26-015664.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015664 |
| 2026-05-07 | 12:10 ET | [8-K](/filings/0001171843-26-003119.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003119 |
| 2026-04-28 | 20:04 ET | [DEF 14A](/filings/0001437749-26-013654.md) | Proxy statement, period 2026-06-11 | 0001437749-26-013654 |
| 2026-04-28 | 20:01 ET | [8-K](/filings/0001437749-26-013638.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-013638 |
| 2026-03-12 | 20:01 ET | [10-K](/filings/0001437749-26-007962.md) | Annual report, period 2025-12-31 | 0001437749-26-007962 |
| 2026-03-12 | 12:15 ET | [8-K](/filings/0001171843-26-001506.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001506 |
| 2026-03-10 | 12:15 ET | [8-K](/filings/0001437749-26-007422.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-007422 |
| 2026-02-19 | 13:15 ET | [8-K](/filings/0001171843-26-000922.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-000922 |
| 2025-12-23 | 13:46 ET | [8-K](/filings/0001437749-25-038605.md) | 1.01 Entry into a material agreement | 0001437749-25-038605 |
| 2025-12-22 | 21:09 ET | [8-K/A](/filings/0001437749-25-038544.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-038544 |
| 2025-12-18 | 22:02 ET | [8-K](/filings/0001437749-25-038313.md) | 8.01 Other events | 0001437749-25-038313 |
| 2025-12-17 | 21:12 ET | [8-K](/filings/0001437749-25-038157.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-038157 |
| 2025-12-03 | 11:27 ET | [8-K](/filings/0001437749-25-036710.md) | 8.01 Other events | 0001437749-25-036710 |
| 2025-11-12 | 21:02 ET | [10-Q](/filings/0001437749-25-034427.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034427 |
| 2025-11-12 | 13:10 ET | [8-K](/filings/0001171843-25-007222.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-007222 |
| 2025-10-24 | 12:10 ET | [8-K](/filings/0001437749-25-031674.md) | 8.01 Other events | 0001437749-25-031674 |
| 2025-10-22 | 12:12 ET | [8-K](/filings/0001437749-25-031466.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-031466 |
| 2025-09-08 | 13:15 ET | [8-K](/filings/0001437749-25-028530.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-028530 |
| 2025-08-14 | 12:15 ET | [10-Q](/filings/0001437749-25-026686.md) | Quarterly report, period 2025-06-30 | 0001437749-25-026686 |
| 2025-08-14 | 11:45 ET | [8-K](/filings/0001171843-25-005406.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005406 |
| 2025-08-04 | 11:45 ET | [8-K](/filings/0001171843-25-004981.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-004981 |
| 2025-06-30 | 11:15 ET | [8-K](/filings/0001171843-25-004211.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-004211 |
| 2025-05-27 | 20:05 ET | [8-K](/filings/0001437749-25-018482.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-018482 |
| 2025-05-08 | 20:01 ET | [10-Q](/filings/0001437749-25-015478.md) | Quarterly report, period 2025-03-31 | 0001437749-25-015478 |
| 2025-05-08 | 12:15 ET | [8-K](/filings/0001171843-25-002954.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002954 |
| 2025-04-21 | 20:37 ET | [8-K](/filings/0001437749-25-012540.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-012540 |
| 2025-04-14 | 11:46 ET | [DEF 14A](/filings/0001437749-25-011848.md) | Proxy statement, period 2025-05-23 | 0001437749-25-011848 |
| 2025-03-25 | 12:15 ET | [8-K](/filings/0001171843-25-001678.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-001678 |
| 2025-03-11 | 19:59 ET | [8-K](/filings/0001437749-25-007019.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-007019 |
| 2025-03-03 | 21:20 ET | [10-K](/filings/0001437749-25-005919.md) | Annual report, period 2024-12-31 | 0001437749-25-005919 |
| 2025-03-03 | 12:40 ET | [8-K](/filings/0001171843-25-001183.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001183 |
| 2025-02-27 | 12:31 ET | [8-K](/filings/0001437749-25-005338.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-005338 |
| 2025-01-07 | 21:40 ET | [8-K](/filings/0001171843-25-000089.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-000089 |
| 2024-11-25 | 12:35 ET | [8-K](/filings/0001171843-24-006545.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-006545 |
| 2024-11-07 | 21:29 ET | [10-Q](/filings/0001437749-24-033944.md) | Quarterly report, period 2024-09-30 | 0001437749-24-033944 |
| 2024-11-07 | 13:10 ET | [8-K](/filings/0001171843-24-006089.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-006089 |
| 2024-10-08 | 12:10 ET | [8-K](/filings/0001437749-24-030845.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-030845 |
| 2024-10-01 | 20:07 ET | [8-K/A](/filings/0001437749-24-030345.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-24-030345 |
| 2024-09-27 | 11:36 ET | [8-K](/filings/0001437749-24-030118.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-030118 |
| 2024-09-17 | 20:22 ET | [8-K](/filings/0001437749-24-029380.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-029380 |
| 2024-09-09 | 12:46 ET | [8-K](/filings/0001171843-24-005116.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-005116 |
| 2024-08-09 | 12:23 ET | [8-K/A](/filings/0001437749-24-025654.md) | 2.02 Results of operations | 0001437749-24-025654 |
| 2024-08-08 | 21:12 ET | [10-Q](/filings/0001437749-24-025611.md) | Quarterly report, period 2024-06-30 | 0001437749-24-025611 |
| 2024-08-08 | 12:13 ET | [8-K](/filings/0001171843-24-004561.md) | 2.02 Results of operations; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001171843-24-004561 |

Page 1 of 7. [Older](/companies/flna/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:03 ET. No prices; not investment advice.